Biotech China 2014

Cancer Biology: Roche AG

Total Score People Score Events Score
37 26 28
Date Event Presentation Speakers
May 23, 2012 Biomarkers World Europe 2012 Molecular biomarkers for Bevacizumab Stefan Scherer
March 26, 2012 World Companion Diagnostics Summit Europe Roche Personalised Healthcare: Identifying Key Factors for the Success of a Personalised Medicine Approach Gerd Maass
Personalised Healthcare in Oncology Drug Discovery & Development at Roche Martin Steegmaier
March 14, 2012 Imaging in Cancer Drug Development New Presentation Werner Scheuer,
Chairman's Opening Remarks Werner Scheuer,
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Epitope characterization and crystal structure of GA101 provide insight into mechanism of action Christian Klein
Panel session Day 3: Bispecific antibodies and antibody-drug-conjugates Ulrich Brinkmann
Bispecific antibodies: CrossMAb and others Christian Klein
Bispecific digoxigenin-binding antibodies for targeted payload delivery Ulrich Brinkmann
March 7, 2011 Imaging in Cancer Drug Development Application of different imaging modalities in the drug development process Werner Scheuer,
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Jinzhi Chen
June 23, 2010 Structure-Based Drug Design TABLE 5: Why Aren’t We Designing the Perfect Drug as Soon as We Have a Crystal Structure? Rama K. Kondru
Mutation Data Driven Binding Modes for CCR5 Antagonists: Applications in Structure Based Design Rama K. Kondru
Beyond Growing and Linking: Impact of Fragments on the Discovery of Kinas e Inhibitors Andreas Kuglstatter
February 24, 2010 5th Annual Bioanalysis in Clinical Research Update on the latest regulatory developments in bioanalysis method validation and study conduct Berthold Lausecker
Interactive panel discussion: Regulated bioanalysis - focus on support of clinical studies Berthold Lausecker
June 16, 2009 4th Annual Cell Based Assays Applying cellular label-free technologies in HTS and in 7TM receptor characterisation analysis Ralph J. Garippa
June 9, 2009 RNAi for Target Identification and Validation I. Surveying RNAi Opportunities: From Tools to Therapies Thomas Singer
April 7, 2009 Inaugural HIV Inhibitors Dual Inhibition of Both HIV and HCV Replication by Novel 2’-Deoxy-Nucleoside Analogs Klaus Klumpp
Binders to HIV-1 RT: Approaches to Improve Mutant Profile and Oral Bioavailability Todd Elworthy
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 1: The application of near-infrared optical imaging in preclinical cancer research Werner Scheuer,
2 : MRI (magnetic resonance imaging) of animal models in preclinical research Basil Künnecke,
December 1, 2008 9th Annual Conference E U R OT I D E S 2008 Opportunities and challenges of developing peptide drugs in the pharmaceutical industry Waleed Danho,
December 1, 2008 European Antibody Congress 2008 GA101, a novel glycoengineered type II CD20 antibody with outstanding anti-tumor efficacy and superior B cell depletion Christian Klein
March 25, 2008 Molecular Diagnostics Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
Organizational, Strategic and Technical Considerations for Creating Clinically Differentiated Medicines and Companion Diagnostics: Successes vs. Failures, What Did We Learn? Tim M. Jaeger
March 25, 2008 Mastering Medicinal Chemistry Purinergic Receptor Antagonists: Novel Treatments for Inflammatory and Neuropathic Pain Michael P Dillon
Discovery and Advancement of 4’-Substituted Nucleosides for the Treatment of Hepatitis C David B Smith
March 25, 2008 R&D Risk Mitigation Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
March 25, 2008 Preclinical Development From Publication to Practice: Interlaboratory Validation of Microarray and QPCR-based Signatures for Predicting Carcinogenicity in the Rat Mark Fielden
March 25, 2008 CANCER MOLECULAR MARKERS Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION D: SCIENTIFIC WRITING AND THE PUBLICATION PROCESS Tom Curran
Dealing with the Necessary Evils: Editors and Reviewers Tom Curran
Targeting the Hedgehog Pathway in Pediatric Brain Tumors Tom Curran
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Nils Heldt
PRECLINICAL DEVELOPMENT AND CHALLENGES: INTERACTIVE PANEL :Partnership and Outsourcing Deals in India – Successes and Failures (17:00-17:45) Nils Heldt
MANAGING GLOBAL ALLIANCES FOR SUCCESS (15:30-17:00) Nils Heldt
MANAGING GLOBAL ALLIANCES FOR SUCCESS: A New Roche Collaboration: Partnering in India and Identifying the Right Candidate to Sup-port Clinical Development Operations (15:30-16:00) Nils Heldt
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS IN PERSONALIZED MEDICINE (13:10-17:00) Stefan Scherer
BIOMARKERS IN PERSONALIZED MEDICINE: Personalized Healthcare and Biomarker Strategies for Cancer Therapeutics (13:45-14:15) Stefan Scherer
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 2: Ultra-High Throughput Sequencing Technologies: Towards Patient Genome Sequencing Michael EGHOLM
Concurrent Session 5: Advances in Cancer Therapeutics Michael EGHOLM
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) TECHnology Platform EXPO (08:25-12:00) Michael Egholm
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Michael Egholm
TECHnology Platform EXPO: Why Length Matters in Next Generation Sequencing (08:35-09:20) Michael Egholm
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies: RNAi Screening to Identify and Validate Therapeutic Targets in Metabolic Diseases (08:40-09:10) John Reidhaar-Olson
In vitro RNAi Screening Strategies (08:30-10:40) John Reidhaar-Olson
In vitro RNAi Screening Strategies: Chairperson’s Remarks (08:30-08:40) John Reidhaar-Olson
Roundtable Discussion Topic: In vitro RNAi Screening (07:30-08:30) John Reidhaar-Olson
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) TECHnology Platform EXPO (08:25-12:00) Michael Egholm
TECHnology Platform EXPO: Why Length Matters in Next Generation Sequencing (08:35-09:20) Michael Egholm
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Michael Egholm
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) Keynote Session 1: Bridging Diagnostics Technologies with Pharma and Biotech (08:45-09:30) Tim M. Jaeger
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY: Proteomic Analysis of Protein-Protein Interaction for Identification of Membrane Markers of Disease (11:30-12:00) Jinzhi Chen
Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY (08:30-16:00) Jinzhi Chen
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.